Quest Diagnostics (DGX) Stock: Buy, Sell, or Hold?
DGX - Quest Diagnostics Inc.
$233.33
2.24 (0.97%)
▲
5d:
-1.27%
30d:
-3.1%
90d:
+9.31%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 22, 2026
18d
Get Alerted When DGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DGX is fairly valued with market pricing in 2.6% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: DGX is fairly valued with market pricing in 2.6% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$287.45
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$178.48
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DGX is currently trading at $233.33, which is considered oversold relative to its 30-day fair value range of $233.57 to $244.23. The stock's valuation (Forward PE: 19.4) is in line with its historical norms (17.9). At these levels, the market is pricing in 2.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DGX is in a strong uptrend. The price is currently testing key support at $227.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DGX scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DGX is in a strong uptrend. The price is currently testing key support at $227.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DGX scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$233.57 -
$244.23
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
53.3%
Protect Your Profits
Holding DGX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($247.73)
- NEUTRAL: Market pricing in 2.6% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$233.57 -
$244.23
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$227.24
Resistance Level
$248.84
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.35
Wall Street Target
$247.73
(+6.2%)
Revenue Growth (YoY)
10.2%
Earnings Growth (YoY)
15.0%
Profit Margin
9.2%
Valuation Premium vs History
+2.6% premium
PE vs Historical
19.4 vs 17.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.6%
(market-implied from PE analysis)
1-Year Target
$239.40
(+3%)
2-Year Target
$245.62
(+5%)
3-Year Target
$252.01
(+8%)
3-Yr Target (if PE normalizes)
(PE: 19→18)
PE COMPRESSION
$233.18
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 7.8%)
$308.05
(+32%)
Base:
(SPY PE: 19.3, Growth: 7.8%)
$292.12
(+25%)
Bear:
(PE: 16.4, Growth: 7.8%)
$248.30
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 24.53 | Current EPS (TTM): $9.42
Bull Case
$325.48
(+40%)
Analyst growth 28.0%, PE expands to 27.0
Base Case
$295.89
(+27%)
Market implied 28.0%, PE stable at 24.5
Bear Case
$157.14
(-33%)
Severe decline -20.0%, PE contracts to 20.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 03, 2026 2:42 PM ET
Data refreshes hourly during market hours. Next update: 3:42 PM
Data refreshes hourly during market hours. Next update: 3:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 49 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 48 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$345 | 67 BUY |
Advanced DGX Option Strategies
Professional options setups generated by AI based on today's DGX price and gamma walls.
